FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/106668 [Registered on: 20/03/2026] Trial Registered Prospectively
Last Modified On: 19/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Siddha
Other (Specify) [VARMA POINT MANIPULATION]  
Study Design  Other 
Public Title of Study   Management of Bronchial Asthma with Varma points manipulation and Internal medicine Muppalai Chooranam 
Scientific Title of Study   AN OPEN LABELLED DOUBLE ARM NON-RANDOMIZED,PHASE-II CLINICAL TRIAL TO COMPARE THE EFFECTIVENESS OF VARMA POINTS MANIPULATION WITH MUPPALAI CHOORANAM(INTERNAL) IN THE MANAGEMENT OF SWASAKASAM (BRONCHIAL ASTHMA) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr S KESAVAN  
Designation  PG SCHOLAR 
Affiliation  Government Siddha Medical College and Hospital, Palayamkottai 
Address  Op no:14, PG Department of Varma maruthuvam, Government Siddha Medical College and Hospital, Palayamkottai

Tirunelveli
TAMIL NADU
627002
India 
Phone  9597923776  
Fax    
Email  k7theesh100@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr S ARUNA MD SIDDHA 
Designation  LECTURER 
Affiliation  Government Siddha Medical College and Hospital, Palayamkottai 
Address  PG Department of Varma Maruthuvam, Government Siddha Medical College and Hospital ,Palayamkottai

Tirunelveli
TAMIL NADU
627002
India 
Phone  9444206633  
Fax    
Email  arunaram1972@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr R KRISHNAMOORTHI MDS 
Designation  Associate Professor and HOD of Department of Varma Maruthuvam 
Affiliation  Government Siddha Medical College and Hospital, Palayamkottai 
Address  PG Department of Varma Maruthuvam, Government Siddha Medical College and Hospital ,Palayamkottai

Tirunelveli
TAMIL NADU
627002
India 
Phone  9442545017  
Fax    
Email  arksiddh@gmail.com  
 
Source of Monetary or Material Support  
Governemnt Siddha Medical College and Hospital ,Palayamkottai ,Tirunelveli - 627002 , Tamilnadu , India 
 
Primary Sponsor  
Name  Government Siddha Medical College and Hospital ,Palayamkottai 
Address  OP No 14 ,PG Department of Varma Maruthuvam ,Government Siddha Medical College and Hospital ,Palayamkottai , Tirunelveli 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr S KESAVAN  Government Siddha Medical College and Hospital  OP no:14 , PG Department of Varma Maruthuvam , Government Siddha Medical college and hospital, Palayamkottai College and Hospital Palayamkottai -627002
Tirunelveli
TAMIL NADU 
9597923776

k7theesh100@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Government Siddha Medical College  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J459||Other and unspecified asthma,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Internal medicine Muppalai chooranam  2gram of chooranam twice daily with honey for 24 days 
Intervention  Varma point manipulation  Stimulation of specified varma points for 24 days 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Adults who are diagnosed with bronchial asthma 2.Patients with a clinical symptoms of swasakasam-recurrent episodes of
wheezing, chest tightness, shortness of breath and dry cough,worse at night or early morning.
3.History of symptoms
triggered by allergens, climatic changes.
4.Patients willing to
provide blood samples for laboratory investigations.
 
 
ExclusionCriteria 
Details  1.Patients with pulmonary Tuberculosis
2.Patients with status asthmaticus
3.Patients with chronic bronchitis, chronic bronchiectasis
4.Patients with heart failure
5.Patients with renal disease
6.Pregnancy and Lactating mothers
7.Diabetes mellitus
8.Hypertension
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Reduction in the severity and frequency of
clinical symptoms of Swasakasam (Bronchial
Asthma), including shortness of breath, chest
tightness, wheezing, and dry cough
 
24 days
 
 
Secondary Outcome  
Outcome  TimePoints 
1.Evaluation of Asthma Control Questionnaire
(ACQ) score following treatment
2.Evalaution of absolute eosinophil count
following treatment
 
24 days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/04/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   An open labelled double arm non randomized phase II  clinical trial to compare the effectiveness of varma point manipulation with muppalai chooranam( internal) in the management of Swasakasam ( Bronchial asthma). 
Varma point manipulation  will be performed at selected Varma points for 24 days.  The dosage of internal medicine Muppalai chooranam is 2 gram twice daily with honey and will be administered for 24 days.
The sample size of the study is 40,  which will be divided into two groups with 20 participants in each group.
 First group will be given Varma point manipulation only for 24 days.
 Second group will be given internal medicine Muppalai chooranam  for 24 days
 
Close